What are GLP-1 medications, and how do they work? GLP-1 drugs, also known as GLP-1 receptor agonists, work by mimicking the effects of a natural hormone called glucagon-like peptide-1 (GLP-1).

A new study led by Ananda Basu, M.D., used novel non-radioactive, stable glucagon tracers for the first time to characterize glucagon metabolism in humans with and without Type 1 diabetes ...

A new study led by Ananda Basu, M.D., used novel non-radioactive, stable glucagon tracers for the first time to characterize glucagon metabolism in humans with and without Type 1 diabetes ...

A new study led by Ananda Basu, M.D., used novel non-radioactive, stable glucagon tracers for the first time to characterize glucagon metabolism in humans with and without Type 1 diabetes, providing ...

Ananda Basu, M.D. A new study led by Ananda Basu, M.D., used novel non-radioactive, stable glucagon tracers for the first time to characterize glucagon metabolism in humans with and without Type 1 ...

JOURNAL NAME: Journal of Biomedical Science and Engineering, Vol.18 No.3, March 28, 2025 ABSTRACT: The increasing use of glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide, for ...

JOURNAL NAME: Journal of Biomedical Science and Engineering, Vol.18 No.3, March 28, 2025 ABSTRACT: The increasing use of glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide, for ...

The addition of a candidate targeting glucagon, as well as GLP-1 and GIP, will add important optionality to our clinical pipeline, as we look to develop a broad portfolio of differentiated treatment ...

The issuer is solely responsible for the content of this announcement. About UBT251 UBT251 is a long-acting synthetic peptide triple agonist targeting the receptors for GLP-1 (glucagon-like peptide-1) ...

Immune cells native to the intestines travel to the pancreas to stimulate glucagon production in pancreatic alpha cells, thereby contributing to the regulation of blood glucose levels, suggests a ...